Hao G. Nguyen MD, PhD, describes the near-infrared, PSMA-targeting fluorophore IS-002, and discusses the background and findings from a phase 1 study of the agent that he presented at the 2022 AUA Annual Meeting. Results of the study showed that IS-002 enabled enhanced intraoperative tumor detection during robotic prostatectomy, according to Nguyen.
Nguyen is associate professor in residence, Urologic Oncology, Richard and Leilani Grinold Endowed professorship in Urology Education, University of California San Francisco.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.